↓ Skip to main content

Dove Medical Press

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and…

Overview of attention for article published in Drug Design, Development and Therapy, July 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
32 Mendeley
Title
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
Published in
Drug Design, Development and Therapy, July 2015
DOI 10.2147/dddt.s86725
Pubmed ID
Authors

YoonJung Choi, HyeKyung Han, Dongseong Shin, Kyoung Soo Lim, Kyung-Sang Yu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 31 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 19%
Student > Master 4 13%
Student > Ph. D. Student 4 13%
Student > Doctoral Student 3 9%
Student > Postgraduate 3 9%
Other 6 19%
Unknown 6 19%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 25%
Medicine and Dentistry 6 19%
Nursing and Health Professions 5 16%
Biochemistry, Genetics and Molecular Biology 2 6%
Sports and Recreations 1 3%
Other 1 3%
Unknown 9 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2023.
All research outputs
#4,835,465
of 25,371,288 outputs
Outputs from Drug Design, Development and Therapy
#304
of 2,268 outputs
Outputs of similar age
#55,877
of 277,602 outputs
Outputs of similar age from Drug Design, Development and Therapy
#16
of 157 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.